NINE MONTHS RESULTS
GlaxoSmithKline Pharmaceuticals Ltd.
BSE
Jun 02, 04:01
3271.55
-23.45 ( -0.71%)
Volume
8744
Prev. Close
3295.00
Open Price
3295.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 02, 03:54
3271.10
-27.50 ( -0.83%)
Volume
208929
Prev. Close
3298.60
Open Price
3298.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
3271.10 (57)
You can view the
Nine Months Results
for the last 5 years.
|
ISIN No
|
INE159A01016
|
Market Cap. ( ₹ in Cr. )
|
55414.41
|
P/BV
|
33.13
|
Book Value ( ₹ )
|
98.74
|
|
BSE Code
|
500660
|
52 Week High/Low ( ₹ )
|
3398/1921
|
FV/ML
|
10/1
|
P/E(X)
|
59.74
|
|
NSE Code
|
GLAXOEQ
|
Book Closure
|
30/05/2025
|
EPS ( ₹ )
|
54.75
|
Div Yield (%)
|
1.65
|
(₹ in Crs.)
| Net Sales/Income from operations | 2757.41 | 2496.38 | 2434.18 | 2425.59 | 2386.46 |
| Total Income From Operations | 2757.41 | 2496.38 | 2434.18 | 2425.59 | 2386.46 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 362.51 | 312.70 | 298.65 | 419.32 | 320.66 |
| Purchase of Traded Goods | 553.71 | 597.34 | 610.64 | 545.34 | 654.31 |
| Increase/Decrease in Stocks | 104.64 | 29.26 | -2.09 | -4.52 | 1.08 |
| Employees Cost | 426.73 | 451.56 | 446.15 | 470.19 | 465.14 |
| Depreciation | 52.07 | 51.58 | 48.59 | 52.84 | 61.43 |
| Other Expenses | 471.27 | 460.18 | 448.18 | 412.85 | 419.11 |
| Total Expenses | 1970.93 | 1902.62 | 1850.12 | 1896.02 | 1921.73 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 786.48 | 593.76 | 584.06 | 529.57 | 464.73 |
| Other Income | 103.10 | 93.61 | 73.55 | 57.28 | 80.58 |
| P/L Before Interest, Excpt. Items & Tax | 889.58 | 687.37 | 657.61 | 586.85 | 545.31 |
| Interest | 0.73 | 1.03 | 1.16 | 1.72 | 2.90 |
| P/L Before Exceptional Items & Tax | 888.85 | 686.34 | 656.45 | 585.13 | 542.41 |
| Exceptional Items | 4.69 | -146.01 | -11.37 | -17.92 | -53.60 |
| P/L Before Tax | 893.54 | 540.33 | 645.08 | 567.21 | 488.81 |
| Tax | 234.62 | 148.72 | 171.86 | 134.76 | 143.99 |
| P/L After Tax from Ordinary Activities | 658.92 | 391.61 | 473.22 | 432.45 | 344.82 |
| Extra Ordinary Item | 0.00 | 0.00 | 3.05 | 40.24 | 0.00 |
| Net Profit/Loss For the Period | 658.92 | 391.61 | 476.27 | 472.69 | 344.82 |
| | | | | | |
| Equity Share Capital | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 38.89 | 29.54 | 28.11 | 27.91 | 20.35 |
| Diluted EPS (Rs.) | 38.89 | 23.12 | 28.11 | 27.91 | 20.35 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 38.89 | 29.54 | 28.11 | 27.91 | 20.35 |
| Diluted EPS (Rs.) | 0.00 | 23.12 | 28.11 | 27.91 | 20.35 |
| | | | | | |
| PBITOE Margin (%) | 28.52 | 23.78 | 23.99 | 21.83 | 19.47 |
| PBTE Margin (%) | 32.23 | 27.49 | 26.96 | 24.12 | 22.72 |
| PBT Margin (%) | 32.40 | 21.64 | 26.50 | 23.38 | 20.48 |
| PAT Margin (%) | 23.89 | 15.68 | 19.56 | 19.48 | 14.44 |